Grünenthal GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.grunenthal.com
Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2018-12-21
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 90
- Registration Number
- NCT03783910
- Locations
- 🇺🇸
005 Research Facility, Charlotte, North Carolina, United States
🇺🇸003 Research Facility, San Antonio, Texas, United States
🇺🇸004 Research Facility, Medford, Oregon, United States
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- Drug: GRT9906 PR tabletDrug: Placebo
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2018-12-14
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT03776110
- Locations
- 🇩🇪
FOCUS Clinical Drug Development GmbH, Neuss, Germany
Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
Phase 1
Completed
- Conditions
- PainPharmacokinetics
- Interventions
- Drug: Transtec 35 µg/hour transdermal patch
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2018-12-10
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT03770234
- Locations
- 🇩🇪
Institut für Klinische Pharmakologie Bobenheim, Grünstadt, Germany
A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused
Phase 1
Completed
- Conditions
- Acute PainPain
- Interventions
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 76
- Registration Number
- NCT03768024
- Locations
- 🇨🇦
DecisionLine Clinical Research Corporation, Toronto, Ontario, Canada
Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 36
- Registration Number
- NCT03766984
- Locations
- 🇲🇽
Clinical Unit of Biodextra, S.A. de C.V., Mexico City, Mexico
Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2018-12-11
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT03767036
- Locations
- 🇲🇽
Investigación Farmacológica y Biofarmacéutica, S.A.P.I de C.V. (IFaB), Mexico City, Mexico
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 259
- Registration Number
- NCT03765697
A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated
Phase 1
Completed
- Conditions
- PainAcute PainChronic Pain
- Interventions
- Drug: GRT0151Y dose escalationDrug: Matching placebo
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT03765658
- Locations
- 🇨🇦
Ventana Clinical Research Corporation, Toronto, Ontario, Canada
A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure
Phase 1
Completed
- Conditions
- Substance Abuse
- Interventions
- Drug: Placebo to match oxycodone API powderDrug: Placebo to match manipulated oxycodone IR ADF.
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 123
- Registration Number
- NCT03765346
- Locations
- 🇨🇦
Algorithme Pharma, Montreal, Canada
A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on it
Phase 1
Completed
- Conditions
- Chronic PainNeuropathic PainVisceral PainPain
- Interventions
- Drug: GRTA9906 60 mg PR tabletDrug: GRTA9906 60 mg IR capsule
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT03765801
- Locations
- 🇩🇪
Dept. of Human Pharmacology, Aachen, Germany
© Copyright 2025. All Rights Reserved by MedPath